We therefore believe that, depending on the context of a certain inflammatory lesion, a clear understanding of the molecular interaction’s mechanisms of various PHD isoforms in the HIF-1α and HIF-2α signaling pathways is required for the beneficial use of PHD for IBD therapy. This evidence concerns the gene EPAS1 and inflammatory bowel disease.